Masimo (MASI) - EV/EBITDA Multiple

Masimo Inc. - graphic logo of issuer MASI

This EV/EBITDA multiple chart demonstrates the position of Masimo Corporation (MASI), a leader in non-invasive monitoring that protects its niche with unique algorithms. High switching costs and a patent moat ensure the stable integration of sensors into hospital equipment. Meanwhile, 28.40 captures the current value of the indicator, highlighting the expansion risks posed by tech giants seeking to certify consumer gadgets as medical devices.

MASI Masimo Personal Health: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 06/21/2026
Manufactured products of Masimo

Institutional capital utilizes this ratio to determine the fair value of Masimo Corporation (MASI), comparing the total enterprise value of the business with its operating profit before depreciation and taxes. An analysis of the company's historical EV/EBITDA levels allows for an assessment of the asset's resilience against the expansion of tech giants into the medtech sector, where patent protection directly impacts the efficiency of cash flow generation.

Competitors of Masimo Corporation

Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stevanato|Teleflex Corp (TFX) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MMSI (Merit Medical Systems)|Enterprise Value to Operating Income Before Depreciation Ratio NVST|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ICU Medical ICUI|Business Value to Operating Income Before Depreciation XRAY|LMAT: Enterprise Value to EBITDA Ratio|ATRC - EV/EBITDA Multiple|STAAR Surgical Company (STAA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ChromaDex|ZIMV (ZimVie) - EV/EBITDA Multiple|Company Value to EBITDA AngioDynamics Inc ANGO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cerus Corp (CERS)|Teknova Inc - Enterprise Value to Operating Income Before Depreciation|Monogram Technologies - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio STSS (Sharps Technology Inc)|INFU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Utah Medical Products Inc. UTMD|korumedical.com (KRMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Nyxoah S.A|MBOT (Microbot Medical Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple pro-dex.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zentek (ZTEK)|Total Company Value to Operating Income Before Depreciation Ratio Elutia Inc|EV/EBITDA Multiple MLSS (Milestone Scientific Corp)|Total Company Value to Operating Income Before Depreciation Ratio NEXGEL Inc (NXGL)|RVP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Harvard Bioscience Inc. (HBIO) - Enterprise Value to EBITDA Ratio|Femasys (FEMY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Meihua Medical Technologies Co., Ltd. (MHUA)|Enterprise Value to EBITDA Ratio POAI|CJMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATRI|Enterprise Value to EBITDA Ratio neurometrix.com NURO